Plain-English translation of NCT07259980 on ClinicalTrials.gov ↗ ·
This is a long-term safety study of , a medication designed to treat a rare form of ALS caused by a mutation in the SOD1 gene. Rather than giving people the medication, this study gathers information from ALS registries and clinical networks to track how safe this treatment is when used in the real world. Researchers want to learn about any serious side effects, especially nervous system problems that were seen in earlier trials, and understand who might benefit most from this medication.
was recently approved to treat SOD1-ALS, but doctors need to understand how safe it really is when many different people use it over months and years. Some serious nervous system side effects were noticed in early studies, so this research aims to carefully watch for these problems and any other safety concerns as more patients take the medication.
You likely qualify if…
You likely don't qualify if…
You would not receive any new medication or attend special visits. Instead, researchers would collect your existing medical records and health information from ALS registries and networks you may already be part of. This information would be reviewed to track your health, any side effects you experience, and how well the medication is working over time—making this a low-burden way to contribute to understanding the long-term safety of this ALS treatment.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States